Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

Previously, we described an oncolytic vesicular stomatitis virus variant pseudotyped with the nonneurotropic glycoprotein of the lymphocytic choriomeningitis virus, VSV-GP, which was highly effective in glioblastoma. Here, we tested its potency for the treatment of ovarian cancer, a leading cause of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Ther Oncolytics
Glavni autori: Dold, Catherine, Rodriguez Urbiola, Carles, Wollmann, Guido, Egerer, Lisa, Muik, Alexander, Bellmann, Lydia, Fiegl, Heidelinde, Marth, Christian, Kimpel, Janine, von Laer, Dorothee
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040171/
https://ncbi.nlm.nih.gov/pubmed/27738655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.21
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items